Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 342

1.

Expression of metalloproteinases and tissue inhibitors of metalloproteinases in giant cell tumor of bone: an immunohistochemical study with clinical correlation.

Schoedel KE, Greco MA, Stetler-Stevenson WG, Ohori NP, Goswami S, Present D, Steiner GC.

Hum Pathol. 1996 Nov;27(11):1144-8.

PMID:
8912822
2.

Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion.

Ueda Y, Imai K, Tsuchiya H, Fujimoto N, Nakanishi I, Katsuda S, Seiki M, Okada Y.

Am J Pathol. 1996 Feb;148(2):611-22.

3.

Immunohistochemical expression of MMP-2, MMP-9, and TIMP-2 in neuroblastoma: association with tumor progression and clinical outcome.

Ara T, Fukuzawa M, Kusafuka T, Komoto Y, Oue T, Inoue M, Okada A.

J Pediatr Surg. 1998 Aug;33(8):1272-8.

PMID:
9722003
5.
6.
7.

Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.

Sutinen M, Kainulainen T, Hurskainen T, Vesterlund E, Alexander JP, Overall CM, Sorsa T, Salo T.

Br J Cancer. 1998 Jun;77(12):2239-45.

8.

Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.

Yokohama Y, Matsumoto T, Hirakawa M, Kuroki Y, Fujimoto N, Imai K, Okada Y.

Lab Invest. 1995 Dec;73(6):899-911.

PMID:
8558853
9.

Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas.

Kawashima A, Okada Y, Nakanishi I, Ueda Y, Iwata K, Roessner A.

Gen Diagn Pathol. 1997 Feb;142(3-4):129-37.

PMID:
9065576
10.

Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.

Iwata H, Kobayashi S, Iwase H, Masaoka A, Fujimoto N, Okada Y.

Jpn J Cancer Res. 1996 Jun;87(6):602-11.

PMID:
8766524
11.

Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix.

Davidson B, Goldberg I, Liokumovich P, Kopolovic J, Gotlieb WH, Lerner-Geva L, Reder I, Ben-Baruch G, Reich R.

Int J Gynecol Pathol. 1998 Oct;17(4):295-301.

PMID:
9785129
12.

Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis.

Kurahara S, Shinohara M, Ikebe T, Nakamura S, Beppu M, Hiraki A, Takeuchi H, Shirasuna K.

Head Neck. 1999 Oct;21(7):627-38.

PMID:
10487950
14.

Regulation of MMP-9 (92 kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone.

Rao VH, Singh RK, Bridge JA, Neff JR, Schaefer GB, Delimont DC, Dunn CM, Sanger WG, Buehler BA, Sawaya R, Nicolson GL, Rao JS.

Clin Exp Metastasis. 1997 Jul;15(4):400-9.

PMID:
9219728
15.

Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas.

Nakatsukasa H, Ashida K, Higashi T, Ohguchi S, Tsuboi S, Hino N, Nouso K, Urabe Y, Kinugasa N, Yoshida K, Uematsu S, Ishizaki M, Kobayashi Y, Tsuji T.

Hepatology. 1996 Jul;24(1):82-8.

PMID:
8707287
16.

High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer.

Grignon DJ, Sakr W, Toth M, Ravery V, Angulo J, Shamsa F, Pontes JE, Crissman JC, Fridman R.

Cancer Res. 1996 Apr 1;56(7):1654-9.

17.

Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta.

Tamarina NA, McMillan WD, Shively VP, Pearce WH.

Surgery. 1997 Aug;122(2):264-71; discussion 271-2.

PMID:
9288131
18.

Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis.

Hayashi T, Stetler-Stevenson WG, Fleming MV, Fishback N, Koss MN, Liotta LA, Ferrans VJ, Travis WD.

Am J Pathol. 1996 Oct;149(4):1241-56.

19.
20.
Items per page

Supplemental Content

Support Center